-
公开(公告)号:EP3280399A1
公开(公告)日:2018-02-14
申请号:EP16717586.8
申请日:2016-04-07
CPC分类号: A61K9/2018 , A61K9/2013 , A61K9/2054 , A61K9/284
摘要: The present invention relates to an immediate-release solid pharmaceutical composition for oral administration containing ivabradine oxalate, and furthermore, to the use of an antioxidant for preventing chemical degradation of ivabradine oxalate in a solid pharmaceutical composition.